PT1343013E - Metodos para o rastreio de compostos moduladores da apoptose compostos identificados por estes metodos e utilizacao destes compostos como agentes terapeuticos - Google Patents
Metodos para o rastreio de compostos moduladores da apoptose compostos identificados por estes metodos e utilizacao destes compostos como agentes terapeuticosInfo
- Publication number
- PT1343013E PT1343013E PT02290578T PT02290578T PT1343013E PT 1343013 E PT1343013 E PT 1343013E PT 02290578 T PT02290578 T PT 02290578T PT 02290578 T PT02290578 T PT 02290578T PT 1343013 E PT1343013 E PT 1343013E
- Authority
- PT
- Portugal
- Prior art keywords
- methods
- apoptotic
- compounds
- screening
- apoptose
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2510/00—Detection of programmed cell death, i.e. apoptosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02290578A EP1343013B1 (en) | 2002-03-07 | 2002-03-07 | Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents. |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1343013E true PT1343013E (pt) | 2006-09-29 |
Family
ID=27741248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT02290578T PT1343013E (pt) | 2002-03-07 | 2002-03-07 | Metodos para o rastreio de compostos moduladores da apoptose compostos identificados por estes metodos e utilizacao destes compostos como agentes terapeuticos |
Country Status (13)
Country | Link |
---|---|
US (2) | US7217534B2 (pt) |
EP (2) | EP1343013B1 (pt) |
JP (1) | JP4414231B2 (pt) |
CN (1) | CN100529759C (pt) |
AT (1) | ATE324589T1 (pt) |
AU (1) | AU2003226678B2 (pt) |
CA (1) | CA2478042A1 (pt) |
CY (1) | CY1105513T1 (pt) |
DE (1) | DE60210919T2 (pt) |
DK (1) | DK1343013T3 (pt) |
ES (1) | ES2262765T3 (pt) |
PT (1) | PT1343013E (pt) |
WO (1) | WO2003075015A2 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2881430B1 (fr) * | 2005-02-01 | 2010-10-22 | Servier Lab | Nouveaux peptides interagissant avec les membres anti-apoptotiques de la famille de proteines bcl-2 et utilisations |
US7897401B2 (en) * | 2005-11-29 | 2011-03-01 | University Of Maryland, College Park | Control of apoptosis by controlling the propensity of ceramide channel formation |
JP2010521183A (ja) * | 2007-03-20 | 2010-06-24 | ザ ウォルター アンド エリザ ホール インスティテュート オブ メディカル リサーチ | スクリーニング法 |
LT2194783T (lt) | 2007-08-10 | 2017-10-25 | Vm Discovery, Inc. | Apoptozės moduliatorių kompozicijos ir būdai |
JP2020524480A (ja) * | 2016-11-03 | 2020-08-20 | セル マイクロシステムズ インクCell Microsystems, Inc. | 特定の数の細胞の自動収集 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3855409A (en) * | 1970-04-01 | 1974-12-17 | Schmid Lab | Method for treating hypercholesterolemia |
WO2000037088A1 (en) * | 1998-12-21 | 2000-06-29 | Inkeysa.Sa | Use of etherlysophospholipids as antiinflammatory agents |
EP1181306A4 (en) * | 1999-05-28 | 2003-06-18 | Apoptosis Technology Inc | COMPOUNDS AND METHODS FOR REGULATING APOPTOSIS, AND METHODS OF MAKING AND SCREENING REGULATORY COMPOUNDS FOR APOPTOSIS |
AU2460601A (en) * | 1999-12-27 | 2001-07-09 | La Jolla Institute For Allergy | Methods for identifying agents capable of modulating protein kinase c theta (pkctheta) activity |
AU2002252015A1 (en) * | 2001-02-16 | 2002-09-04 | Arbor Vita Corporation | Pdz domain interactions and lipid rafts |
-
2002
- 2002-03-07 DE DE60210919T patent/DE60210919T2/de not_active Expired - Lifetime
- 2002-03-07 EP EP02290578A patent/EP1343013B1/en not_active Expired - Lifetime
- 2002-03-07 ES ES02290578T patent/ES2262765T3/es not_active Expired - Lifetime
- 2002-03-07 PT PT02290578T patent/PT1343013E/pt unknown
- 2002-03-07 AT AT02290578T patent/ATE324589T1/de active
- 2002-03-07 DK DK02290578T patent/DK1343013T3/da active
-
2003
- 2003-03-07 AU AU2003226678A patent/AU2003226678B2/en not_active Ceased
- 2003-03-07 CA CA002478042A patent/CA2478042A1/en not_active Abandoned
- 2003-03-07 CN CNB038101785A patent/CN100529759C/zh not_active Expired - Fee Related
- 2003-03-07 EP EP03743394A patent/EP1481250A2/en not_active Withdrawn
- 2003-03-07 JP JP2003573423A patent/JP4414231B2/ja not_active Expired - Fee Related
- 2003-03-07 WO PCT/EP2003/002921 patent/WO2003075015A2/en active Application Filing
-
2005
- 2005-05-31 US US11/140,275 patent/US7217534B2/en not_active Expired - Fee Related
-
2006
- 2006-07-17 CY CY20061100987T patent/CY1105513T1/el unknown
-
2007
- 2007-04-05 US US11/696,804 patent/US20070184435A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2262765T3 (es) | 2006-12-01 |
WO2003075015A2 (en) | 2003-09-12 |
JP2005518813A (ja) | 2005-06-30 |
CN1650169A (zh) | 2005-08-03 |
CA2478042A1 (en) | 2003-09-12 |
US7217534B2 (en) | 2007-05-15 |
DE60210919D1 (de) | 2006-06-01 |
EP1343013A1 (en) | 2003-09-10 |
EP1343013B1 (en) | 2006-04-26 |
JP4414231B2 (ja) | 2010-02-10 |
AU2003226678B2 (en) | 2009-12-10 |
CY1105513T1 (el) | 2010-04-28 |
DE60210919T2 (de) | 2007-05-10 |
US20060040331A1 (en) | 2006-02-23 |
US20070184435A1 (en) | 2007-08-09 |
DK1343013T3 (da) | 2006-08-21 |
CN100529759C (zh) | 2009-08-19 |
WO2003075015A3 (en) | 2003-12-24 |
EP1481250A2 (en) | 2004-12-01 |
AU2003226678A1 (en) | 2003-09-16 |
ATE324589T1 (de) | 2006-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20110483A (es) | Preparacion de pregabalina y compuestos relacionados (divisional de expediente 8765) | |
SG170116A1 (en) | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides | |
NZ603648A (en) | Methods of purifying polypeptides | |
CR8997A (es) | Produccion de polipeptidos | |
WO2007022515A3 (en) | Stem cell derived factors for treating pathologic conditions | |
PT1969007E (pt) | Composições e métodos para a produção de uma composição | |
WO2004071795A8 (en) | Hard tonneau cover | |
SI1863920T1 (sl) | Postopek za izboljšano izolacijo rekombinantno proizvedenih proteinov | |
DE602005024050D1 (de) | Abdichtungsmaterial für solarzellen | |
IL164531A (en) | Immunomodulatory compounds for modulating mammalian cd34+ or cd133+ hematopoietic stem cells differentiation | |
WO2007079130A3 (en) | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides | |
WO2003099210A3 (en) | Methods of modulating tubulin deacetylase activity | |
NZ551828A (en) | A method of cell isolating a homogenous population of mammary stem cells using specific cell surface marker proteins | |
BR9710303A (pt) | Processos para altera-Æo de crescimento de cabelo e pigmenta-Æo de cabelo por apoptose nas papilas foliculares e composi-{es para os mesmos | |
PT1343013E (pt) | Metodos para o rastreio de compostos moduladores da apoptose compostos identificados por estes metodos e utilizacao destes compostos como agentes terapeuticos | |
WO2007041213A3 (en) | Methods for regulation of p53 translation and function | |
UA84406C2 (ru) | Способ обеспечения резистентности к грибковому или грибоподобному патогену в однодольных растениях | |
FR2858410B1 (fr) | Procede de determination des contraintes, deformations, endommagement de pieces constituees d'un materiau solide. | |
BR112012011598A2 (pt) | polipeptídeos de haemophilus parasuis e métodos de uso | |
ES2479543T1 (es) | Poblaciones celulares que tienen actividad inmunorreguladora, métodos para la preparación y usos de las mismas | |
ATE384079T1 (de) | Marker für stammzellen und dessen verwendung | |
EP1968155A4 (en) | METHOD FOR SEPARATING THE ACTIVE MATERIAL FROM AN ELECTRODE PLATE FOR A STORAGE BATTERY | |
DE60322882D1 (de) | T zell-subpopulation zur regelung der darmimmunität | |
ITMI20031909A1 (it) | Linee cellulari di mammifero modificate per la produzione di glicoproteine ricombinanti. | |
HK1110736A1 (en) | Improved cell search for handover conditions |